Sarna, G <br/><br/>
Phase I study of recombinant beta ser 17 interferon in the treatment of cancer.  [electronic resource] 

 -  Cancer treatment reports  Dec 1986 
 - 1365-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0361-5960 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2',5'-Oligoadenylate Synthetase--analysis<br/>Adult<br/>Aged<br/>Antibodies--analysis<br/>Chemical and Drug Induced Liver Injury<br/>Drug Administration Schedule<br/>Drug Evaluation<br/>Female<br/>Hematologic Diseases--chemically induced<br/>Humans<br/>Interferon Type I--adverse effects<br/>Interferon beta-1a<br/>Interferon beta-1b<br/>Interferon-beta<br/>Kidney Diseases--chemically induced<br/>Kinetics<br/>Lymphocytes--enzymology<br/>Male<br/>Middle Aged<br/>Nausea--chemically induced<br/>Neoplasms--blood<br/>Recombinant Proteins--adverse effects